Ilkka Tikkanen
Impact in
- Nephrology top 1%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
-
- Heart Failure Treatment and Management
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
Papers in
-
- Renin-Angiotensin System Studies 21
- Heart Failure Treatment and Management 17
- Blood Pressure and Hypertension Studies 9
-
- Protein Hydrolysis and Bioactive Peptides 8
- Co-authors
- Frej Fyhrquist (45 shared papers)Kaj Metsärinne (5 shared papers)Hans J. Woerle (5 shared papers)Uli C. Broedl (5 shared papers)Eeva Palojoki (10 shared papers)Päivi Lakkisto (34 shared papers)Cordula Zeller (3 shared papers)Kari Pulkki (7 shared papers)
- Journals
- Hypertension (10 papers)Journal of Hypertension (10 papers)European Journal of Pharmacology (8 papers)Kidney International (5 papers)Clinical Science (4 papers)
- Partner nations
- FinlandUnited StatesAustralia
In The Last Decade
Ilkka Tikkanen
162 papers receiving 4.5k citations
Ilkka Tikkanen's Hit Papers
Peers
Comparison fields: 5 of 121
- Nephrology 567
- Cardiology and Cardiovascular Medicine 1.6k
- Endocrinology, Diabetes and Metabolism 988
- Pulmonary and Respiratory Medicine 568
- Surgery 673
Countries citing papers authored by Ilkka Tikkanen
This map shows the geographic impact of Ilkka Tikkanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilkka Tikkanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilkka Tikkanen more than expected).
Fields of papers citing papers by Ilkka Tikkanen
This network shows the impact of papers produced by Ilkka Tikkanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilkka Tikkanen. The network helps show where Ilkka Tikkanen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ilkka Tikkanen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 388 | |
| 2 | Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension Hit paper breakdown → | 2014 | 381 |
| 3 | 2001 | 256 | |
| 4 | 2017 | 186 | |
| 5 | 2001 | 138 | |
| 6 | 2001 | 134 | |
| 7 | 2000 | 119 | |
| 8 | 2001 | 94 | |
| 9 | Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. | 1994 | 93 |
| 10 | 2016 | 90 | |
| 11 | 1980 | 80 | |
| 12 | 2001 | 77 | |
| 13 | 1998 | 68 | |
| 14 | 2002 | 67 | |
| 15 | 2010 | 62 | |
| 16 | 2002 | 62 | |
| 17 | 2007 | 59 | |
| 18 | 1998 | 59 | |
| 19 | 1996 | 58 | |
| 20 | 2021 | 55 |
About Ilkka Tikkanen
Ilkka Tikkanen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Nephrology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 166 papers that have together received 4.6k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (21 papers), Heart Failure Treatment and Management (17 papers), Renal Diseases and Glomerulopathies (11 papers), Hormonal Regulation and Hypertension (10 papers), Blood Pressure and Hypertension Studies (9 papers), Diabetes Treatment and Management (9 papers), Protein Hydrolysis and Bioactive Peptides (8 papers) and Nitric Oxide and Endothelin Effects (8 papers). The work is most often cited by research in Nephrology (567 citations), Cardiology and Cardiovascular Medicine (1.6k citations), Endocrinology, Diabetes and Metabolism (988 citations), Pulmonary and Respiratory Medicine (568 citations) and Surgery (673 citations). Ilkka Tikkanen has collaborated with scholars based in Finland, United States and Australia. Frequent co-authors include Frej Fyhrquist, Kaj Metsärinne, Hans J. Woerle, Uli C. Broedl, Eeva Palojoki, Päivi Lakkisto, Cordula Zeller, Kari Pulkki, Carola Grönhagen‐Riska and Afshin Salsali. Their work appears in journals such as Hypertension, Journal of Hypertension, European Journal of Pharmacology, Kidney International and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.